Testosterone and weight loss: the evidence

Purpose of reviewThe purpose of this article is to examine the contemporary data linking testosterone therapy in overweight and obese men with testosterone deficiency to increased lean body mass, decreased fat mass, improvement in overall body composition and sustained weight loss. This is of paramount importance because testosterone therapy in obese men with testosterone deficiency represents a novel and a timely therapeutic strategy for managing obesity in men with testosterone deficiency. Recent findingsLong-term testosterone therapy in men with testosterone deficiency produces significant and sustained weight loss, marked reduction in waist circumference and BMI and improvement in body composition. Further, testosterone therapy ameliorates components of the metabolic syndrome. The aforementioned improvements are attributed to improved mitochondrial function, increased energy utilization, increased motivation and vigor resulting in improved cardio-metabolic function and enhanced physical activity. SummaryThe implication of testosterone therapy in management of obesity in men with testosterone deficiency is of paramount clinical significance, as it produces sustained weight loss without recidivism. On the contrary, alternative therapeutic approaches other than bariatric surgery failed to produce significant and sustained outcome and exhibit a high rate of recidivism. These findings represent strong foundations for testosterone therapy in obese men with testosterone deficiency and should spur clinical research for better understanding of usefulness of testosterone therapy in treatment of underlying pathophysiological conditions of obesity.

• Publication year

  2014

• Venue

  Current Opinion in Endocrinology, Diabetes & Obesity

• Publication date

  2014-08-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MED.0000000000000086PMID 25105998PMCID 4154787
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Independent Effects of Testosterone on Lipid Oxidation and VLDL-TG Production: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

  2014cited by this paper
• Impact of body composition during weight change on resting energy expenditure and homeostasis model assessment index in overweight nonsmoking adults.

  2014cited by this paper
• Acute and short-term chronic testosterone fluctuation effects on glucose homeostasis, insulin sensitivity, and adiponectin: a randomized, double-blind, placebo-controlled, crossover study.

  2014cited by this paper
• Testosterone with dutasteride, but not anastrazole, improves insulin sensitivity in young obese men: a randomized controlled trial.

  2014cited by this paper
• Testosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: the BLAST study.

  2014cited by this paper
• Testosterone supplementation and sexual function: a meta-analysis study.

  2014cited by this paper
• 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society.

  2014cited by this paper
• Death by testosterone? We think not!

  2014cited by this paper
• Current pharmacotherapy for obesity: extrapolation of clinical trials data to practice

  2014influential reference
• Effects of Long-Term Testosterone Therapy on Patients with “Diabesity”: Results of Observational Studies of Pooled Analyses in Obese Hypogonadal Men with Type 2 Diabetes

  2014cited by this paper
• Effects of Five-Year Treatment with Testosterone Undecanoate on Metabolic and Hormonal Parameters in Ageing Men with Metabolic Syndrome

  2014cited by this paper
• Hypogonadal obese men with and without diabetes mellitus type 2 lose weight and show improvement in cardiovascular risk factors when treated with testosterone: an observational study.

  2014cited by this paper
• The effect of antiobesity drugs on waist circumference: a mixed treatment comparison

  2014cited by this paper
• Adipocyte mitochondrial function is reduced in human obesity independent of fat cell size.

  2014cited by this paper
• Musculoskeletal and prostate effects of combined testosterone and finasteride administration in older hypogonadal men: a randomized, controlled trial.

  2014cited by this paper
• Increased Risk of Non-Fatal Myocardial Infarction Following Testosterone Therapy Prescription in Men

  2014cited by this paper
• Androgen-deprivation therapy and diabetes control among diabetic men with prostate cancer.

  2014cited by this paper
• Effects of testosterone undecanoate replacement and withdrawal on cardio-metabolic, hormonal and body composition outcomes in severely obese hypogonadal men: a pilot study

  2014cited by this paper
• Androgen-deprivation therapy in treatment of prostate cancer and risk of myocardial infarction and stroke: a nationwide Danish population-based cohort study.

  2014cited by this paper
• The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study)

  2014cited by this paper
• A new era of testosterone and prostate cancer: from physiology to clinical implications.

  2014cited by this paper
• Long‐term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss

  2013cited by this paper
• IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men.

  2013cited by this paper
• Effects of testosterone treatment on body composition in males with testosterone deficiency syndrome

  2013cited by this paper
• Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis.

  2013cited by this paper
• Effects of oral testosterone undecanoate therapy on bone mineral density and body composition in 322 aging men with symptomatic testosterone deficiency: a 1-year, randomized, placebo-controlled, dose-ranging study

  2013cited by this paper
• Medication adherence and treatment patterns for hypogonadal patients treated with topical testosterone therapy: a retrospective medical claims analysis.

  2013cited by this paper
• Impact of androgen deprivation therapy on mental and emotional well-being in men with prostate cancer: analysis from the CaPSURE™ registry.

  2013cited by this paper
• Risks and Benefits of Late Onset Hypogonadism Treatment: An Expert Opinion

  2013cited by this paper
• 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults

  2013cited by this paper
• Gonadal steroids and body composition, strength, and sexual function in men.

  2013cited by this paper
• Can Diabetes Be Surgically Cured? Long-Term Metabolic Effects of Bariatric Surgery in Obese Patients with Type 2 Diabetes Mellitus

  2013cited by this paper
• New options for the treatment of obesity and type 2 diabetes mellitus (narrative review).

  2013cited by this paper
• Prostatic Diseases and Male Voiding Dysfunction Effects of 5-Year Treatment With Testosterone Undecanoate on Lower Urinary Tract Symptoms in Obese Men With Hypogonadism and Metabolic Syndrome

  2013cited by this paper
• Independent Effects of Testosterone on Lipid Oxidation and VLDL-TG Production

  2013cited by this paper
• Age as a Predictive Factor of Testosterone Improvement in Male Patients After Bariatric Surgery: Preliminary Results of a Monocentric Prospective Study

  2013cited by this paper
• Words of wisdom. Re: Gonadal steroids and body composition, strength, and sexual function in men.

  2013cited by this paper
• Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study.

  2013cited by this paper
• Androgens inhibit adipogenesis during human adipose stem cell commitment to preadipocyte formation.

  2013cited by this paper
• Metabolic syndrome, circulating RBP4, testosterone, and SHBG predict weight regain at 6 months after weight loss in men

  2013cited by this paper
• Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study

  2013cited by this paper
• A 6-month observational study of energy, sexual desire, and body proportions in hypogonadal men treated with a testosterone 1% gel

  2013cited by this paper
• Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels.

  2013cited by this paper
• Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss

  2013cited by this paper
• Determinants of testosterone recovery after bariatric surgery: is it only a matter of reduction of body mass index?

  2013cited by this paper
• Screening for and Management of Obesity in Adults: U.S. Preventive Services Task Force Recommendation Statement

  2012cited by this paper
• Deletion of the Androgen Receptor in Adipose Tissue in Male Mice Elevates Retinol Binding Protein 4 and Reveals Independent Effects on Visceral Fat Mass and on Glucose Homeostasis

  2012cited by this paper
• Testosterone therapy decreases subcutaneous fat and adiponectin in aging men.

  2012cited by this paper
• Testosterone treatment improves metabolic syndrome-induced adipose tissue derangements.

  2012cited by this paper
• Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study

  2012cited by this paper
• Testosterone as Potential Effective Therapy in Treatment of Obesity in Men with Testosterone Deficiency: A Review

  2012cited by this paper
• Goodbye androgen hypothesis, hello saturation model.

  2012cited by this paper
• Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnoea: a randomised placebo-controlled trial.

  2012cited by this paper
• Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS)

  2012cited by this paper
• Treat obesity as physiology, not physics

  2012cited by this paper
• A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up

  2012cited by this paper
• Testosterone therapy increased muscle mass and lipid oxidation in aging men

  2011cited by this paper
• Obesity induces signs of premature cardiac aging in younger patients: the role of mitochondria.

  2011cited by this paper
• Comparing effects of a low-energy diet and a high-protein low-fat diet on sexual and endothelial function, urinary tract symptoms, and inflammation in obese diabetic men.

  2011cited by this paper
• Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

  2011cited by this paper
• Emerging targets for the treatment of obesity

  2011cited by this paper
• Low testosterone in men with type 2 diabetes: significance and treatment.

  2011cited by this paper
• Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study)

  2011cited by this paper
• Angiopoietin‐like proteins: emerging targets for treatment of obesity and related metabolic diseases

  2011cited by this paper
• Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS)

  2011cited by this paper
• Hypothalamic malonyl‐CoA and CPT1c in the treatment of obesity

  2011cited by this paper
• Androgen deficiency and mitochondrial dysfunction: implications for fatigue, muscle dysfunction, insulin resistance, diabetes, and cardiovascular disease

  2011cited by this paper
• Testosterone undecanoate improves erectile dysfunction in hypogonadal men with the metabolic syndrome refractory to treatment with phosphodiesterase type 5 inhibitors alone

  2011cited by this paper
• Testosterone and metabolic syndrome: a meta-analysis study.

  2011cited by this paper
• Emerging therapies in the treatment of 'diabesity': beyond GLP-1.

  2011cited by this paper
• Increased adiposity in DNA binding-dependent androgen receptor knockout male mice associated with decreased voluntary activity and not insulin resistance.

  2011cited by this paper
• Higher testosterone levels are associated with less loss of lean body mass in older men.

  2011cited by this paper
• Obesity stresses cardiac mitochondria even when you are young.

  2011cited by this paper
• Induced testosterone deficiency: from clinical presentation of fatigue, erectile dysfunction and muscle atrophy to insulin resistance and diabetes

  2011cited by this paper
• A Small-Scale Clinical Trial to Determine the Safety and Efficacy of Testosterone Replacement Therapy in Hypogonadal Men with Spinal Cord Injury

  2011cited by this paper
• Testosterone Concentrations in Diabetic and Nondiabetic Obese Men

  2010cited by this paper
• Prevalence, incidence and risk factors of testosterone deficiency in a population-based cohort of men: results from the study of health in Pomerania

  2010cited by this paper
• Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study.

  2010cited by this paper
• Adverse events associated with testosterone administration.

  2010cited by this paper
• The therapeutics of lifestyle management on obesity

  2010cited by this paper
• Effects of Testosterone Undecanoate on Cardiovascular Risk Factors and Atherosclerosis in Middle-Aged Men with Late-Onset Hypogonadism and Metabolic Syndrome : Results from a 24-month , Randomized , Double-Blind , Placebo-Controlled Studyjsm

  2010cited by this paper
• Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study.

  2010cited by this paper
• Effects of testosterone on skeletal muscle architecture in intermediate-frail and frail elderly men.

  2010cited by this paper
• Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome.

  2010cited by this paper
• Androgens and obesity

  2010cited by this paper
• Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double‐blinded placebo‐controlled Moscow study

  2010cited by this paper
• Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study.

  2010cited by this paper
• Diabesity: therapeutic options

  2010cited by this paper
• Effects of Testosterone on Muscle Strength, Physical Function, Body Composition, and Quality of Life in Intermediate-Frail and Frail Elderly Men: A Randomized, Double-Blind, Placebo-Controlled Study

  2010cited by this paper
• Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone.

  2009cited by this paper
• Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth.

  2009cited by this paper
• Androgen deficiency: effects on body composition

  2008cited by this paper
• Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip

  2008cited by this paper
• Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial.

  2008cited by this paper
• Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men.

  2008cited by this paper
• Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity.

  2007cited by this paper
• The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes.

  2007cited by this paper
• Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes

  2007cited by this paper
• The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men.

  2007cited by this paper
• Diagnosing and treating testosterone deficiency in different parts of the world. Results from global market research

  2007cited by this paper

• Biological mechanisms of dopamine D2-like receptor agonist therapy in diabetes

  2025cites this paper
• Clomiphene or enclomiphene citrate for the treatment of male hypogonadism: a systematic review and meta-analysis of randomized controlled trials

  2025cites this paper
• Role of Sex Hormones in Mediating Adiposity Changes from Weight Loss in People with Type 2 Diabetes: Look AHEAD Sex Hormone Study.

  2025cites this paper
• Long-Term Testosterone Shows Cardiovascular Safety in Men With Testosterone Deficiency in Electronic Health Records

  2025cites this paper
• Relação da Testosterona com a Obesidade e a Hipertensão Arterial

  2024cites this paper
• Clomiphene Citrate Administered in Periconception Phase Causes Fetal Loss and Developmental Impairment in Mice

  2024cites this paper
• Relationship between Serum Total Testosterone Concentration and Metabolic Syndrome in Premenopausal Obese Women

  2024cites this paper
• Sexual Dimorphism's Impact on Adipogenesis: A Three-dimensional In Vitro Model Treated with 17β-estradiol and Testosterone.

  2024cites this paper
• The Role of SHBG as a Marker in Male Patients with Metabolic-Associated Fatty Liver Disease: Insights into Metabolic and Hormonal Status

  2024cites this paper
• The Effects of Testosterone Replacement Therapy in Adult Men With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-analysis

  2024cites this paper
• Relationship of Testosterone with Obesity and Arterial Hypertension

  2024cites this paper
• The effects of exercise training on insulin resistance in children and adolescents with overweight or obesity: a systematic review and meta-analysis

  2023cites this paper
• Correlation Analysis between Hypogonadal Symptoms and Changes in Body Composition and Physical Fitness after Testosterone Treatment in Men with Testosterone Deficiency

  2023cites this paper
• Management of Male Infertility with Coexisting Sexual Dysfunction: A Consensus Statement and Clinical Recommendations from the Asia-Pacific Society of Sexual Medicine (APSSM) and the Asian Society of Men’s Health and Aging (ASMHA)

  2023cites this paper
• EMAS position statement: Testosterone replacement therapy in older men.

  2023cites this paper
• Up to the maximum—testosterone dose‐dependent effects on anabolic and androgen responsive tissues in orchiectomized rats

  2023cites this paper
• Neurosteroid, Natural and Anabolic Steroids: Physiological, Immunological and Histopathological Study on Diabetic Albino Rats

  2023cites this paper
• Male Hypogonadism (According to the Materials of the European Association of Urology)

  2022cites this paper
• The male patient with obesity undergoing metabolic and bariatric surgery: changes in testosterone levels correlate with weight loss after one-anastomosis gastric bypass and Roux-en-Y gastric bypass.

  2022cites this paper
• Effects of aging and the body mass index on male sex hormones: a cross-sectional study in 701 Brazilian men

  2022cites this paper
• Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin

  2022cites this paper
• The association of serum testosterone with dyslipidemia is mediated by obesity: the Henan Rural Cohort Study

  2022cites this paper
• Endogenous Androgens Diminish Food Intake and Activation of Orexin A Neurons in Response to Reduced Glucose Availability in Male Rats

  2022cites this paper
• Insulin sensitivity as a predictor of longitudinal changes on body mass index in Brazilian adolescents

  2022cites this paper
• Dehydroepiandrosterone (DHEA) Improves the Metabolic and Haemostatic Disturbances in Rats with Male Hypogonadism

  2022cites this paper
• Long-term exposure to particulate matter and residential greenness in relation to androgen and progesterone levels among rural Chinese adults.

  2021cites this paper
• Glycemic benefits with adherence to testosterone therapy in men with hypogonadism and type 2 diabetes mellitus

  2021cites this paper
• Co-Treatment of Purified Annatto Oil (Bixa orellana L.) and Its Granules (Chronic®) Improves the Blood Lipid Profile and Bone Protective Effects of Testosterone in the Orchiectomy-Induced Osteoporosis in Wistar Rats

  2021cites this paper
• Endocrine Disrupting Chemicals-induced Metabolic Disorders and Treatment Strategies

  2021cites this paper
• Differential effects of 11 years of long-term injectable testosterone undecanoate therapy on anthropometric and metabolic parameters in hypogonadal men with normal weight, overweight and obesity in comparison with untreated controls: real-world data from a controlled registry study

  2020cites this paper
• Effective Smart Sensors Based Cognitive Infocommunications Weight Loss System

  2020cites this paper
• Androgen effect on body weight and behaviour of male and female rats: novel insight on the clinical value

  2020cites this paper
• Herbs and Spices as Natural Medicine for Treatment of Metabolic Disorders

  2020cites this paper
• Testosterone Therapy in Male Infertility

  2020cites this paper
• Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males

  2020cites this paper
• EFFECTS OF HONEY ON PROSTATE GLAND FUNCTION AND SERUM TESTOSTERONE LEVEL IN ADULT MALE WISTAR RATS

  2020cites this paper
• Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine.

  2019cites this paper
• Remission of type 2 diabetes and pleiotropic effects of long-term testosterone treatment for “late-onset” hypogonadism: A case report

  2019cites this paper
• Benefits and Risks of Testosterone Therapy in Men With Testosterone Deficiency

  2019cites this paper
• Lean Tissue Index and Body Cell Mass Can Be Predictors of Low Free Testosterone Levels in Men on Hemodialysis.

  2019cites this paper
• Testosterone and Men's Health

  2019cites this paper
• SERUM TESTOSTERONE LEVEL IN TYPE 2 DIABETES MELLITUS MALES: A REVIEW IN URBAN POPULATION OF PAKISTAN

  2019cites this paper
• Effectiveness of testosterone therapy in obese men with low testosterone levels, for losing weight, controlling obesity complications, and preventing cardiovascular events

  2018influential citation
• The Anti-Inflammatory Effects of Testosterone

  2018cites this paper
• Gonadal Dysfunction in Males with Overweight or Obesity, and Adiposopathy

  2018cites this paper
• Impact of Testosterone Deficiency and Testosterone Therapy on Lower Urinary Tract Symptoms in Men with Metabolic Syndrome

  2018cites this paper
• Korean red ginseng (Panax ginseng) inhibits obesity and improves lipid metabolism in high fat diet-fed castrated mice.

  2018cites this paper
• The association between serum testosterone and mortality among elderly men on hemodialysis

  2018cites this paper
• Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency.

  2018cites this paper
• Racial/Ethnic Differences in the Association Between Energy Balance and Prostate Cancer

  2018cites this paper
• Metabolic phenotype of male obesity-related secondary hypogonadism pre-replacement and post-replacement therapy with intra-muscular testosterone undecanoate therapy

  2018cites this paper
• Testosterone a key factor in gender related metabolic syndrome

  2018influential citation
• Transcriptome signatures of p,p´-DDE-induced liver damage in Mus spretus mice.

  2018cites this paper
• Alterations in Body Uneasiness, Eating Attitudes, and Psychopathology Before and After Cross-Sex Hormonal Treatment in Patients with Female-to-Male Gender Dysphoria

  2018cites this paper
• The complex association between metabolic syndrome and male hypogonadism.

  2018cites this paper
• Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in Men with Hypogonadism

  2017influential citation
• Korean Red Ginseng (Panax ginseng) Potentiates the Inhibitory Actions of Testosterone on Obesity and Adipogenesis in High Fat Diet-Fed Castrated Mice

  2017cites this paper
• Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men

  2017cites this paper
• Administration of Increasing Doses of Gonadotropin Releasing Hormone in Men with Spinal Cord Injury to Investigate Dysfunction of the Hypothalamic-Pituitary-Gonadal Axis

  2017cites this paper
• Testosterone Replacement Therapy and Components of the Metabolic Syndrome.

  2017cites this paper
• Practical Use of Pharmacotherapy for Obesity.

  2017cites this paper
• Ketogenic diet and testosterone increase: Is the increased cholesterol intake responsible? To what extent and under what circumstances can there be benefits?

  2017cites this paper
• Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.

  2017cites this paper
• Sexual dysfunction and central obesity in patients with first episode psychosis

  2017cites this paper
• Visceral Adipose Tissue and Leptin Hyperproduction Are Associated With Hypogonadism in Men With Chronic Kidney Disease.

  2017cites this paper
• Laparoscopic Sleeve Gastrectomy

  2017cites this paper
• Solicitações de frações livres de hormônios tireoidianos, espermograma e globulina ligadora de hormônios sexuais na obesidade: uma perspectiva atual à prática clínica

  2017cites this paper
• Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?

  2016cites this paper
• RAS and sex differences in diabetic nephropathy.

  2016cites this paper
• The Author's Reply: Changing testosterone had no direct effect on HbA1c or weight in diabetic men when TRT was interrupted and then resumed

  2016cites this paper
• Characterization of 5α-reductase activity and isoenzymes in human abdominal adipose tissues.

  2016cites this paper
• Metabolic and behavioral effects of mutant huntingtin deletion in Sim1 neurons in the BACHD mouse model of Huntington’s disease

  2016cites this paper
• Testosterone deficiency in the aging male

  2016cites this paper
• Effects of Lifestyle Changes and Testosterone Therapy on Erectile Function

  2016cites this paper
• Testosterone and the Prostate: Artifacts and Truths.

  2016cites this paper
• Connecting the obesity and the narcissism epidemics.

  2016cites this paper
• Testosterone is Protective Against Cardiac Disease: Con.

  2016cites this paper
• Exogenous Testosterone, Aging, and Changes in Behavioral Response of Gonadally Intact Male Mice

  2016cites this paper
• Bulbocavernosus muscle area as a novel marker for hypogonadism

  2016cites this paper
• Is polycystic ovary syndrome a sexual conflict? A review.

  2016cites this paper
• [Testosterone deficit: what's new?].

  2015cites this paper
• Metabolic Syndrome, Obesity Paradox and Testosterone Level

  2015cites this paper
• Effects of Testosterone Replacement Therapy on Cardio-Metabolic, Hormonal and Anthropometric Parameters in Obese Hypogonadal Men with Metabolic Syndrome

  2015cites this paper
• The complex and multifactorial relationship between testosterone deficiency (TD), obesity and vascular disease

  2015influential citation
• Testosteronmangel

  2015cites this paper
• Testosterone and obesity

  2015cites this paper
• Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studies

  2015cites this paper
• Effects of testosterone on the spatial ecology, coloration, and brain regions in western fence lizards, Sceloporus occidentalis

  2015cites this paper
• Testosterone and metabolic syndrome

  2015cites this paper
• Hormones and the heart

  2015cites this paper
• Overselling hysteria, dangerously: the media coverage of testosterone therapy in men

  2015cites this paper
• Testosterone Replacement Therapy on the Natural History of Prostate Disease

  2015cites this paper
• Horizons in the Pharmacotherapy of Obesity

  2015cites this paper
• Endothelial Dysfunction and Cardiovascular Disease: Hyperbaric Oxygen Therapy as an Emerging Therapeutic Modality?

  year unknowncites this paper
• Short Editorial Relationship of Testosterone with Obesity and Arterial Hypertension

  year unknowncites this paper